Global Irritable Bowel Syndrome Market 2018-2026: Epidemiology, Patient Flow, Prevalence and Diagnosed & Treated Patient Analysis - ResearchAndMarkets.com

DUBLIN--()--The "Global Irritable Bowel Syndrome Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.

The research provides insights into Irritable Bowel Syndrome epidemiology, Irritable Bowel Syndrome diagnosed patients, and Irritable Bowel Syndrome treatment rate for US, Japan, and EU5 countries. The research measures key indicators including prevalence of Irritable Bowel Syndrome derived from epidemiological analysis, patients diagnosed with Irritable Bowel Syndrome, and patients treated with a drug therapy.

The research study helps executives estimate Irritable Bowel Syndrome market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Irritable Bowel Syndrome prevalence, Irritable Bowel Syndrome diagnosis rate, and Irritable Bowel Syndrome treatment rate for the period 2017-2026. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan.

Key Topics Covered

1. Irritable Bowel Syndrome: Disease Definition

2. Global Irritable Bowel Syndrome Patient Flow

3. Irritable Bowel Syndrome Patient Flow in the US

4. Irritable Bowel Syndrome Patient Flow in Europe

5. Irritable Bowel Syndrome Patient Flow in Germany

6. Irritable Bowel Syndrome Patient Flow in France

7. Irritable Bowel Syndrome Patient Flow in Spain

8. Irritable Bowel Syndrome Patient Flow in Italy

9. Irritable Bowel Syndrome Patient Flow in UK

10. Irritable Bowel Syndrome Patient Flow in Japan

11. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/d8xhkg/global_irritable?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Gastrointestinal Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Gastrointestinal Drugs